Background The VASCADE closure device has been widely used to close arteriotomy sites following femoral procedures; however, little data have been published regarding the device''s utility in closure of venotomy sites after procedures such as right‐heart catheterization. Methods This was a ...
Vascular access safety in all three studies was similar to that in the AMBULATE pivotal study, i.e. zero major access site-related complications. Same-Day Discharge #3, an all-comers study for patients undergoing AF ablation with venous closure using Vascade MVP, will begin enrolme...
VASCADE MVP Venous Vascular Closure System (VVCS)产品名称,P120016 S024申请号,pma申请类型,CARDIVA MEDICAL, INC.申请人,数据来源于药智数据美国上市器械数据库。
UCA Grounding and UCAO Splice Closure 4 Pages Plug & Play? Universal Systems 24 Pages ALTOS® Lite? Gel-Free, Single-Jacket, Single-Armor Cables, 6-288 Fibers 4 Pages ALTOS® Triple-Jacket, Double-Armored Cables, 12-192 Fibers 4 Pages VFL-350 Visual Fault Locator 2 Pages OV-10...
vascular closure devicevenotomyWATCHMANBackground The VASCADE MVP venous vascular closure system is commonly used for percutaneous venotomy closure in catheter-based procedures utilizing sheath sizes 6-12 French. However, its application with larger sheaths such as ones required in left atrial appendage...
Methods: This is a single centre retrospective review of all patients who had percutaneous hepatic or splenic venous access obtained in the cardiac catheterisation laboratory from March 1, 2022 through October 30, 2023 and underwent tract closure with VASCADE. Results: Ten patients (six male) ...
Efficacy and safety of the VASCADE MVP venous vascular closure device in patients undergoing percutaneous left atrial appendage occlusion with WATCHMANdoi:10.1002/ccd.31209Golzarian, HafezGraebel, Katherine T.Bailey, RachelWidmer, Michael B.Thiel, Arielle...
VASCADE vascular‐closure devicevascular injuryObjectives To analyze post‐marketing surveillance data from the United States Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database for the VASCADE Vascular Closure System (Cardiva Medical Inc., Santa Clara, ...
This single-center, retrospective study describes using the VASCADE Vascular Closure System (Cardiva Medical, Inc, Santa Clara, California) to close 32 venous access sites in 21 consecutive patients (11 females; 10 males; age 45 y ± 19) after catheter-directed interventions. Sheath sizes were ...
Study to Demonstrate the Safety and Efficacy of the CARDIVA VASCADE Vascular Closure System (VCS) versus Manual Compression,Cardiva Medical, Inc,Interventional,Not Applicable